Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Annala, Matti, Vandekerkhove, Gillian, Khalaf, Daniel, Taavitsainen, Sinja, Beja, Kevin, Warner, Evan W, Sunderland, Katherine, Kollmannsberger, Christian, Eigl, Bernhard J, Finch, Daygen, Oja, Conrad D, Vergidis, Joanna, Zulfiqar, Muhammad, Azad, Arun A, Nykter, Matti, Gleave, Martin E, Wyatt, Alexander W, Chi, Kim N
Published in Cancer discovery (01.04.2018)
Published in Cancer discovery (01.04.2018)
Get full text
Journal Article
Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
Annala, Matti, Taavitsainen, Sinja, Khalaf, Daniel J, Vandekerkhove, Gillian, Beja, Kevin, Sipola, Joonatan, Warner, Evan W, Herberts, Cameron, Wong, Amanda, Fu, Simon, Finch, Daygen L, Oja, Conrad D, Vergidis, Joanna, Zulfiqar, Muhammad, Eigl, Bernhard J, Kollmansberger, Christian K, Nykter, Matti, Gleave, Martin E, Chi, Kim N, Wyatt, Alexander W
Published in Clinical cancer research (15.08.2021)
Published in Clinical cancer research (15.08.2021)
Get full text
Journal Article
Effect of Metformin vs Placebo on Weight and Metabolic Factors in NCIC CTG MA.32
Goodwin, Pamela J, Parulekar, Wendy R, Gelmon, Karen A, Shepherd, Lois E, Ligibel, Jennifer A, Hershman, Dawn L, Rastogi, Priya, Mayer, Ingrid A, Hobday, Timothy J, Lemieux, Julie, Thompson, Alastair M, Pritchard, Kathleen I, Whelan, Timothy J, Mukherjee, Som D, Chalchal, Haji I, Oja, Conrad D, Tonkin, Katia S, Bernstein, Vanessa, Chen, Bingshu E, Stambolic, Vuk
Published in JNCI : Journal of the National Cancer Institute (01.03.2015)
Published in JNCI : Journal of the National Cancer Institute (01.03.2015)
Get full text
Journal Article
Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32
Goodwin, Pamela J, Parulekar, Wendy R, Gelmon, Karen A, Shepherd, Lois E, Ligibel, Jennifer A, Hershman, Dawn L, Rastogi, Priya, Mayer, Ingrid A, Hobday, Timothy J, Lemieux, Julie, Thompson, Alastair M, Pritchard, Kathleen I, Whelan, Timothy J, Mukherjee, Som D, Chalchal, Haji I, Oja, Conrad D, Tonkin, Katia S, Bernstein, Vanessa, Chen, Bingshu E, Stambolic, Vuk
Published in JNCI : Journal of the National Cancer Institute (01.03.2015)
Published in JNCI : Journal of the National Cancer Institute (01.03.2015)
Get full text
Journal Article
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial
Khalaf, Daniel J, Annala, Matti, Taavitsainen, Sinja, Finch, Daygen L, Oja, Conrad, Vergidis, Joanna, Zulfiqar, Muhammad, Sunderland, Katherine, Azad, Arun A, Kollmannsberger, Christian K, Eigl, Bernhard J, Noonan, Krista, Wadhwa, Deepa, Attwell, Andrew, Keith, Bruce, Ellard, Susan L, Le, Lyly, Gleave, Martin E, Wyatt, Alexander W, Chi, Kim N
Published in The lancet oncology (01.12.2019)
Published in The lancet oncology (01.12.2019)
Get full text
Journal Article
Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial
Goodwin, Pamela J, Chen, Bingshu E, Gelmon, Karen A, Whelan, Timothy J, Ennis, Marguerite, Lemieux, Julie, Ligibel, Jennifer A, Hershman, Dawn L, Mayer, Ingrid A, Hobday, Timothy J, Bliss, Judith M, Rastogi, Priya, Rabaglio-Poretti, Manuela, Mukherjee, Som D, Mackey, John R, Abramson, Vandana G, Oja, Conrad, Wesolowski, Robert, Thompson, Alastair M, Rea, Daniel W, Stos, Paul M, Shepherd, Lois E, Stambolic, Vuk, Parulekar, Wendy R
Published in JAMA : the journal of the American Medical Association (24.05.2022)
Published in JAMA : the journal of the American Medical Association (24.05.2022)
Get full text
Journal Article
Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial
Khalaf, Daniel J., Sunderland, Katherine, Eigl, Bernhard J., Kollmannsberger, Christian K., Ivanov, Nikita, Finch, Daygen L., Oja, Conrad, Vergidis, Joanna, Zulfiqar, Muhammad, Gleave, Martin E., Chi, Kim N.
Published in European urology (01.06.2019)
Published in European urology (01.06.2019)
Get full text
Journal Article
Quality of life (QOL) for the treatment sequence of abiraterone acetate plus prednisone (AAP) followed by enzalutamide (ENZ) versus the opposite sequence for metastatic castration-resistant prostate cancer (mCRPC): Results from a phase II randomized clinical trial
Khalaf, Daniel J, Sunderland, Katherine, Eigl, Bernhard J., Finch, Daygen L., Oja, Conrad D., Vergidis, Joanna, Zulfiqar, Muhammad, Kollmannsberger, Christian K., Gleave, Martin, Chi, Kim N.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Abstract GS1-08: CCTGMA.32, a phase III randomized double-blind placebo controlled adjuvant trial of metformin (MET) vs placebo (PLAC) in early breast cancer (BC): Results of the primary efficacy analysis (clinical trials.gov NCT01101438)
Goodwin, Pamela J., Chen, Bingshu E, Gelmon, Karen A, Whelan, Timothy J, Ennis, Marguerite, Lemieux, Julie, Ligibel, Jennifer A, Hershman, Dawn L, Mayer, Ingrid A, Hobday, Timothy J, Bliss, Judith M, Rastogi, Priya, Rabaglio-Poretti, Manuela, Mukherjee, Som D., Mackey, Robert R, Abramson, Vandana G, Oja, Conrad, Wesolowski, Robert, Thompson, Alastair M, Rea, Daniel W, Stos, Paul M, Shepherd, Lois E, Stambolic, Vuk, Parulekar, Wendy R
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Influence of dose on liposome clearance: critical role of blood proteins
Oja, Conrad D., Semple, Sean C., Chonn, Arcadio, Cullis, Pieter R.
Published in Biochimica et biophysica acta (22.05.1996)
Published in Biochimica et biophysica acta (22.05.1996)
Get full text
Journal Article
Doxorubicin entrapped within liposome-associated antigens results in a selective inhibition of the antibody response to the linked antigen
Oja, Conrad, Tardi, Paul, Schutze-Redelmeier, Marie-Paule, Cullis, Pieter R.
Published in Biochimica et biophysica acta (29.09.2000)
Published in Biochimica et biophysica acta (29.09.2000)
Get full text
Journal Article
HSD3B1 (1245A>C) polymorphism and clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate (AA) and enzalutamide (ENZA): Results from two prospective studies
Aragon, Isabel, Khalaf, Daniel Joseph, Lozano, Rebeca, Annala, Matti, Taavitsainen, Sinja, Lorente, David, Finch, Daygen L., Romero-Laorden, Nuria, Vergidis, Joanna, Cendon, Ylenia, Oja, Conrad D., Pacheco, Maria I, Zulfiqar, Muhammad, Gleave, Martin, Wyatt, Alexander William, Olmos, David, Castro, Elena, Chi, Kim N.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
A randomized phase II cross-over study of abiraterone + prednisone (ABI) vs enzalutamide (ENZ) for patients (pts) with metastatic, castration-resistant prostate cancer (mCRPC)
Chi, Kim N., Annala, Matti, Sunderland, Katherine, Khalaf, Daniel, Finch, Daygen, Oja, Conrad D., Vergidis, Joanna, Zulfiqar, Muhammad, Beja, Kevin, Vandekerkhove, Gillian, Gleave, Martin, Wyatt, Alexander William
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Assessment of quality of life (QOL), cognitive function and depression in a randomized phase II study of abiraterone acetate (ABI) plus prednisone (P) vs enzalutamide (ENZA) for metastatic castrate-resistant prostate cancer (mCRPC)
Khalaf, Daniel, Sunderland, Katherine, Eigl, Bernhard J., Finch, Daygen L., Oja, Conrad D., Vergidis, Joanna, Parimi, Sunil, Zulfiqar, Muhammad, Gleave, Martin, Chi, Kim N.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase 2 randomized cross-over trial of abiraterone + prednisone (ABI+P) vs enzalutamide (ENZ) for patients (pts) with metastatic castration resistant prostate cancer (mCPRC): Results for 2nd-line therapy
Khalaf, Daniel, Annala, Matti, Finch, Daygen L., Oja, Conrad D., Vergidis, Joanna, Zulfiqar, Muhammad, Sunderland, Katherine, Beja, Kevin, Vandekerkhove, Gillian Rae, Gleave, Martin, Wyatt, Alexander William, Chi, Kim N.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Circulating tumor DNA (ctDNA) and correlations with clinical prognostic factors in patients with metastatic castration-resistant prostate cancer (mCRPC)
Khalaf, Daniel, Annala, Matti, Beja, Kevin, Vandekerkhove, Gillian, Zulfiqar, Muhammad, Finch, Daygen L., Oja, Conrad D., Vergidis, Joanna, Gleave, Martin, Wyatt, Alexander William, Chi, Kim N.
Published in Journal of clinical oncology (20.02.2017)
Published in Journal of clinical oncology (20.02.2017)
Get full text
Journal Article
Circulating tumor DNA (ctDNA) burden and actionable mutations in treatment-naïve metastatic castration-resistant prostate cancer (mCRPC)
Wyatt, Alexander William, Annala, Matti, Parimi, Sunil, Zulfiqar, Muhammad, Finch, Daygen L., Oja, Conrad D., Vergidis, Joanna, Azad, Arun, Gleave, Martin, Chi, Kim N.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Effects of abiraterone (ABI) and enzalutamide (ENZA) on cognitive impairment and depressive symptoms in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Parimi, Sunil, Eigl, Bernhard J., Sunderland, Katherine, Zulfiqar, Muhammad, Finch, Daygen L., Oja, Conrad D., Vergidis, Joanna, Seto, Leanne Chung-Yan, Azad, Arun, Gleave, Martin, Chi, Kim N.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article